First CRISPR Gene Editing Treatment for Sickle Cell Disease
In the history of sickle-cell anaemia, UK and FDA approve gene therapy for the first time! It's a real game [...]
In the history of sickle-cell anaemia, UK and FDA approve gene therapy for the first time! It's a real game [...]
Institut Imagine (Paris) will coordinate a Horizon Europe-granted project on genome editing approaches to treat sickle cell disease [...]
Click here to read more about the genome engineering with Cas9 and adeno-associated virus strategies! Abstract for General public Genome editing using [...]
After three years of project, the Consortium will meet in person on September 15th and 16th, 2025 to debrief. A [...]
A Scientific meeting will be held on November 27th, 2025 on Teams with all Consortium members to present ongoing experiments and updated [...]
A Scientific meeting will be held on May 30th, 2025 on Teams with all Consortium members to present ongoing experiments and updated [...]
A Scientific meeting will be held on March 19th, 2025 on Teams with all Consortium members to present ongoing experiments and updated [...]
Members of EDITSCD Consortium will join the Synthego Seminar in Paris to discuss sgRNA manufacturing, CRISPR nucleases for therapeutic development [...]
Congress Europe 2024 The World Orphan Drug Congress is the largest and most established orphan drugs & rare diseases meeting of its [...]
The ERN-EuroBloodNet Progress Meetings, are organized every autumn by the ERN-EuroBloodNet Coordination team, to promote networking among the haematologic stakeholders with the aim of identifying needs [...]
Learn more about sickle cell anemia, a genetic disease that affects millions of people worldwide, with the screening of the [...]
19th Annual Sickle Cell & Thalassaemia Conference Hosted by the Academy for Sickle Cell and Thalassaemia (ASCAT), in collaboration with the [...]
For World Sickle Cell Day 2024, ERN-EuroBloodNet is gathering the voices of people living with Sickle Cell Disease globally via [...]
Members of EDITSCD Consortium will join the Hemoglobin switching meeting in Puerto Rico to discuss about haemoglobinopathies, globin gene expression, [...]
Click here to read more about the need to personalize genome-editing experiments! Abstract for General public Variations within the human genome affect [...]
The Institute of Bioorganic Chemistry of the Polish Academy of Sciences has joined the project! As part of the "Hop-on facility" [...]
31th annual congress of ESGCT This year ESGCT will take place at Rome. Members of EDITSCD Consortium will join the meeting!
Wang, Jinglong, et al. « DNA-PKcs Suppresses Illegitimate Chromosome Rearrangements ». Nucleic Acids Research, février 2024, p. gkae140. https://doi.org/10.1093/nar/gkae140
Click here to read more about the latest groundbreaking ex vivo prime editing results! [...]
Health Bioscience Research Industry Days, Paris, France HYBRID is the convergence of a scientific congress, where the latest advances are presented [...]
ASGCT's Annual Meeting is the premier event for professionals in gene and cell therapy. The five-day meeting is the best [...]
Tools, Delivery, Safety/Off-target, Diseases, Pre-clinical/clinical, Standards and Regulations | Functional Genomics, Target Identification and Target Validation Meet the European CRISPR Medicine/Genomic [...]
Click to find how targeting the bone marrow niche could improve gene therapy outcome! [...]
65th American Society of Hematology Annual Meeting & Exposition The 65th ASH Annual Meeting and Exposition will take place December 9-12, [...]
CRISPR-Cas: From biology to therapeutic applications EMBO Workshops are selected for their excellent scientific quality and provision of good networking activities [...]